IMUX Jan 2025 2.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 09:46AM EDT
| Previous close | 0.1500 |
| Open | 0.1500 |
| Bid | 0.1000 |
| Ask | 0.2000 |
| Strike | 2.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.1500 - 0.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | 698 |
Simply Wall St.When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?
With the business potentially at an important milestone, we thought we'd take a closer look at Immunic, Inc.'s...
PR NewswireImmunic to Participate in Industry and Scientific Conferences in June
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and scientific conferences in June:
Insider MonkeyImmunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript
Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript May 8, 2024 Immunic, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Jessica Breu: Good morning, and welcome to Immunic First Quarter 2024 Earnings Call. My name is Jessica Breu, Vice President, […]
© 2024 Yahoo. All rights reserved.